| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/17/2011 | EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods |
| 08/17/2011 | EP2356236A1 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION |
| 08/17/2011 | EP2355842A1 Priming of an immune response |
| 08/17/2011 | EP1668144B1 Nucleotide sequences promoting the trans-membrane transport of nucleic acids |
| 08/17/2011 | EP1610612B1 Endosomolytic polymers |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | EP1404841B1 Cyp1b1 nucleic acids and methods of use |
| 08/17/2011 | EP1327003B1 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 08/17/2011 | EP0939827B1 Lentiviral vectors |
| 08/17/2011 | CN1924014B Interference RNA sequence of specificity interference MTA1 mRNA for inhibiting tumor metastasis |
| 08/17/2011 | CN102159713A Vectors for delivery of light-sensitive proteins and methods of use |
| 08/17/2011 | CN102159709A New therapeutic agent for malignant mesothelioma and immunostimulant |
| 08/17/2011 | CN102159241A Tapasin augmentation for enhanced immune response |
| 08/17/2011 | CN102159235A Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use |
| 08/17/2011 | CN102154482A Application of calcium activated chloride channels ANO1/TMEM16A in diagnosis and treatment of prostate cancer |
| 08/17/2011 | CN102154368A Tissue specificity and regulation lentivirus gene expression vector |
| 08/17/2011 | CN102154293A Small-interfering RNA (siRNA) capable of inhibiting classical swine fever virus (CSFV) reproduction and infection as well as preparation method and application thereof |
| 08/17/2011 | CN102154292A siRNA fragment of c-Met gene and application thereof |
| 08/17/2011 | CN102154290A SiRNAs for inhibiting epidemic encephalitis B viruses |
| 08/17/2011 | CN102154259A Preparation method and use of genetic engineering preparation for dissolving blood platelet thrombi |
| 08/17/2011 | CN102154223A Recombinant adenovirus with fusion protein gene and preparation method and application thereof |
| 08/17/2011 | CN102154210A Method for preparing hepatic stem cell decorated by insulin gene and application and preparation thereof |
| 08/17/2011 | CN102153650A Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153649A Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof |
| 08/17/2011 | CN102153648A EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof |
| 08/17/2011 | CN102153647A Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153640A Anticoagulation protein of tick and gene and application thereof |
| 08/17/2011 | CN102151337A Compositions and methods for regulated protein expression in gut |
| 08/17/2011 | CN102151334A Antibody against a tumor-specific antigen as target |
| 08/17/2011 | CN102151333A Vaccination against host cell-associated herpesviruses |
| 08/17/2011 | CN101845419B Recombinant adenovirus and application thereof |
| 08/17/2011 | CN101475996B Novel use of alpha-fetoprotein and encoding gene thereof |
| 08/17/2011 | CN101439189B Use of zebra fish Caspy2 gene in preparing medicament for treating tumor |
| 08/17/2011 | CN101250529B Horse infectious anemia virus soluble acceptor, coded sequence and uses thereof |
| 08/16/2011 | US8000902 Methods and compositions for selecting siRNA of improved functionality |
| 08/16/2011 | US7999073 Expression vector comprising nucleotide sequences coding nucleoprotein filaments for improving heterologous gene expression in cells |
| 08/16/2011 | US7998941 Hypoxia inducible VEGF plasmid for ischemic disease |
| 08/16/2011 | US7998939 Aptamers that bind thrombin with high affinity |
| 08/16/2011 | US7998736 Adoptive immunotherapy with enhanced T lymphocyte survival |
| 08/16/2011 | US7998734 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders |
| 08/16/2011 | US7998680 Determining genotype of a polymorphic site in the hereditary hemochromatosis gene |
| 08/16/2011 | US7998507 Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors |
| 08/16/2011 | US7998492 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 08/16/2011 | US7998477 Spherical protein particles and methods for making and using them |
| 08/16/2011 | US7998472 CD34 stem cell-related methods and compositions |
| 08/16/2011 | US7998471 Mycobacteria expressing HIV-1 and malaria antigens |
| 08/16/2011 | CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 08/16/2011 | CA2411925C Immunization of dairy cattle with mig protein |
| 08/16/2011 | CA2397590C Antisense inhibition of ptp1b expression |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/16/2011 | CA2321837C Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 08/16/2011 | CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 08/11/2011 | WO2011097582A2 Treatment of arachidonate 12-lipoxygenase, 12r type (alox12b) related diseases by inhibition of natural antisense transcript to alox12b |
| 08/11/2011 | WO2011097492A1 A dna sequence that confers aphid resistance in soybean |
| 08/11/2011 | WO2011097456A2 Compositions and methods for enhanced parvovirus transduction |
| 08/11/2011 | WO2011097027A2 Novel methods and utilities |
| 08/11/2011 | WO2011094806A1 Diagnostic and prognostic assay for breast cancer |
| 08/11/2011 | WO2011022606A3 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 08/11/2011 | WO2011015701A3 Lipid nanoparticles for gene therapy |
| 08/11/2011 | US20110196023 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 08/11/2011 | US20110196022 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 08/11/2011 | US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins |
| 08/11/2011 | US20110196019 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/11/2011 | US20110196018 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 08/11/2011 | US20110196017 Micro-rna that promotes vascular integrity and uses thereof |
| 08/11/2011 | US20110195903 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195124 Phase-transition polymeric microneedles |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | DE102010007562A1 Dermatologische, pharmazeutische Zusammensetzung geeignet für Oligonukleotide Dermatological pharmaceutical composition suitable for oligonucleotides |
| 08/11/2011 | CA2788682A1 Compositions and methods for enhanced parvovirus transduction |
| 08/10/2011 | EP2354149A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/10/2011 | EP2353651A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders |
| 08/10/2011 | EP2353615A2 Compositions and methods for treating inflammatory lung disease |
| 08/10/2011 | EP2353614A1 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 08/10/2011 | EP2353389A1 Methods and compositions for treating disorders |
| 08/10/2011 | EP2352830A2 Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1 |
| 08/10/2011 | EP2352823A1 Porphobilinogen deaminase gene therapy |
| 08/10/2011 | EP2352527A1 Modulation of toll-like receptor 2 expression by antisense oligonucleotides |
| 08/10/2011 | EP1747277B1 Gene delivery to neuronal cells |
| 08/10/2011 | EP1565581B1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/10/2011 | EP1509617B1 Light emitting microorganisms and viruses for diagnosis of diseases associated with wounded or inflamed tissue |
| 08/10/2011 | EP1430157B1 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/10/2011 | EP1135513B2 Adenovirus-mediated gene therapy |
| 08/10/2011 | EP0935001B2 Novel vegf-like factors |
| 08/10/2011 | CN1741821B Compositions for cancer treatment |
| 08/10/2011 | CN102149820A Cell capable of expressing exogenous GITR ligand |
| 08/10/2011 | CN102149412A Hepatoprotectant acetaminophen mutual prodrugs |
| 08/10/2011 | CN102146454A Use of SLC 19A3 gene |
| 08/10/2011 | CN102146418A Recombinant II type herpes simplex virus vector, preparation method of recombinant II type herpes simplex virus vector, recombinant virus, medicinal composition and application |
| 08/10/2011 | CN102146412A Small molecular non-coding RNA gene hsa-miR-29b and use thereof |
| 08/10/2011 | CN102146411A Novel bifunctional cicatrix and tissue fibrosis resistant oligonucleotide medicament |
| 08/10/2011 | CN102145181A siRNA for inhibiting tumor growth and oligomeric nucleic acid combination and application of siRNA |
| 08/10/2011 | CN102145180A Application of miR-34c in preparation of medicaments or health-care products for treating or preventing liver cancers |
| 08/10/2011 | CN102145179A Application of IL-1ra-Fcepsilon fusion gene and coded protein thereof to treatment on allergic rhinitis |
| 08/10/2011 | CN102145177A Method for preparing folate molecular targeted magnetic nanometer medicine carrier and targeting gene medicine |
| 08/10/2011 | CN102145167A Recombinant human metapneumovirus vaccine |
| 08/10/2011 | CN102145163A Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 08/10/2011 | CN102144973A Prescription composition of optimized siRNA cation liposome |